Bionoia Where life meets thought ⌕
Back to Journal
Journal › Mucosa
Discovery

Polysaccharide from Atractylodes macrocephala Koidz. protects against avian pathogenic Escherichia coli-induced intestinal barrier Dysfunction via Suppressing PI3K/Akt-Mediated Claudin-2 upregulation

Read original paper

Source: [pubmed](https://pubmed.ncbi.nlm.nih.gov/42184735/)

Authors: Chen S, Qu X, Wu J

Venue: Poult Sci · 2026 May 15

AI relevance (5/5): Directly addresses intestinal barrier dysfunction, claudin tight junction proteins, and mechanistic signaling pathway (PI3K/Akt) in gut mucosa.

--- *Draft auto-created from Suggestions queue. Polish the body, set is_real=true when verified, and publish via `INSERT INTO bionoia_published` when ready for /public/.*

Related articles in this corpus

Parallel
LEF1 gene mutation impairs the intestinal barrier and causes diarrhea
Both articles examine distinct molecular mechanisms underlying intestinal barrier dysfunction and diarrhea, but operate through different pathways (PI3K/Akt-claudin signaling versus LEF1 gene mutation) without direct mechanistic overlap.
Parallel
LEF1 gene mutation impairs the intestinal barrier and causes diarrhea
Both articles investigate intestinal barrier dysfunction through distinct molecular pathways (PI3K/Akt-claudin-2 signaling vs. LEF1 gene regulation), addressing the same physiological outcome of barrier impairment and diarrhea from different mechanistic angles.
Parallel
Mechanism of Inonotus hispidus in suppressing renal cell carcinoma proliferation via regulation of the PI3K/AKT/mTOR pathway
Both articles investigate how natural polysaccharide/fungal compounds suppress disease progression through PI3K/AKT pathway inhibition, but in different disease contexts (intestinal barrier dysfunction vs. renal carcinoma) with different molecular targets.
Parallel
Effect of Oral Calcium Butyrate Supplementation in Obesity
Both articles address intestinal barrier function and metabolic health through natural compounds, but examine different mechanisms (polysaccharide signaling vs. butyrate supplementation) in distinct disease contexts (bacterial infection vs. obesity).
Published 2026-05-29 · Last kit-update 2026-05-29